SUBSCRIBERS
Tylenol maker to pay US$25m for selling metal-contaminated medicine
Published Wed, Mar 11, 2015 · 09:50 PM
Washington
A JOHNSON & Johnson subsidiary pleaded guilty on Tuesday to selling liquid medicine contaminated with metal and agreed to pay US$25 million to resolve the case, the US Department of Justice said on Tuesday.
The subsidiary, McNeil Consumer Healthcare, pleaded guilty to one federal criminal charge in the case.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Consumer & Healthcare
HCA beats first-quarter profit estimates on higher patient admissions
US FDA approves Pfizer’s gene therapy for rare bleeding disorder
EU toughens rules on Chinese fashion retailer Shein
Best World under fire from shareholders at AGM over dividends, director salaries
‘Extreme’ climate blamed for world’s worst wine harvest in 62 years
Sheng Siong Q1 net profit up 9.3% on higher revenue